WallStSmart
OSTX

OS Therapies Incorporated

AMEX: OSTX · HEALTHCARE · BIOTECHNOLOGY

$1.71
+2.78% today

Updated 2026-06-04

Market cap
$77.50M
P/E ratio
P/S ratio
EPS (TTM)
$-1.07
Dividend yield
52W range
$1 – $3
Volume
0.8M

OS Therapies Incorporated (OSTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$4250.00$1.16M$805.00$4220.00$2780.00$363085.00
Gross profit$-4250.00$-1.16M$-805.00$-4220.00$-2780.00$-363085.00
Gross margin
R&D$601.00$2.17M$3.29M$3.22M$2.84M$16.36B
SG&A$795.00$1.50M$1.15M$1.12M$3.97M$12.34B
Operating income$-5647.00$-4.84M$-4.45M$-4.34M$-6.81M$-28.71M
Operating margin
EBITDA$-5647.00$-4.84M$-4.45M$-4.34M$-6.83M$-28.39M
EBITDA margin
EBIT$-5647.00$-4.84M$-4.45M$-4.34M$-6.83M$-28.75M
Interest expense$461.79M$2.58M$1.81M$3.45M$2.05M$0.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-6027.00$-7.42M$-6.25M$-7.79M$-8.88M$-28.75M
Net income growth (YoY)-123016.8%+15.7%-24.6%-14.0%-223.7%
Profit margin

Frequently asked questions

How much free cash flow does OSTX generate?

OSTX produced $-14.24B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is OSTX's balance sheet healthy?

OSTX holds $269.83M in cash and equivalents against — in long-term debt, on $-6.10M of shareholder equity. That debt is best read against the cash flow the business throws off each year.